Jiang Y et al.ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).Blood Cancer J 6:e465 (2016).
Buscemi G et al.Bimodal regulation of p21(waf1) protein as function of DNA damage levels.Cell Cycle 13:2901-12 (2014).
Cavalieri S et al.Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO).Eur J Hum Genet 21:774-8 (2013).
Valdez BC et al.The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.Biochem Pharmacol 81:222-32 (2011).
Larsen DH et al.The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage.J Cell Biol 190:731-40 (2010).
Liu H et al.Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint.Nature 467:343-6 (2010).
Guervilly JH et al.Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.Hum Mol Genet 17:679-89 (2008).
Brem R et al.The methyl methanesulfonate induced S-phase delay in XRCC1-deficient cells requires ATM and ATR.DNA Repair (Amst) 7:849-57 (2008).
Bartkova J et al.DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.Nature 434:864-70 (2005).
Horejsí Z et al.Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.Oncogene 23:3122-7 (2004).
Goldberg M et al.MDC1 is required for the intra-S-phase DNA damage checkpoint.Nature 421:952-6 (2003).
Yazdi PT et al.SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.Genes Dev 16:571-82 (2002).
DiTullio RA et al.53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.Nat Cell Biol 4:998-1002 (2002).